🔎 Trials Near Me

Beranda › Tumor Stromal Gastrointestinal › Pennsylvania

Uji klinis Tumor Stromal Gastrointestinal di Pennsylvania

6 studi untuk Tumor Stromal Gastrointestinal mencari peserta di lokasi di Pennsylvania.

Kota di Pennsylvania

Teks studi resmi (Bahasa Inggris)

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Pittsburgh
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07218926

DESTINY-PANTUMOUR04

  • Research Site, Philadelphia
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

  • Fox Chase Cancer Center, Philadelphia
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07406633

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Thomas Jefferson University, Philadelphia
Menerima pesertaFase 2
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

  • Fox Chase Cancer Center, Philadelphia
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT05957367

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

  • Thomas Jefferson University, Philadelphia
  • Temple University Health System, Philadelphia
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT06655246

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.